Skip to content

Clinical trials

Diabetic Neuropathies trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Country / region: Canada Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20051
20062
20072
20081
20104
20111
20122
20141
20181
20191
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status3
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
McMaster University2
Takeda2
University of Calgary2
AbbVie (prior sponsor, Abbott)1
Chromaderm, Inc.1
Group Health Centre1
LMC Diabetes & Endocrinology Ltd.1
Novartis Pharmaceuticals1
Ottawa Hospital Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies23
Diabetes Mellitus6
Pain5
Diabetes Mellitus, Type 14
Diabetes Mellitus, Type 24
Neuralgia4
Diabetes Complications3
Agnosia1
Angina Pectoris1
Chronic Pain1

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.